• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Bortezomib-induced cardiogenic shock in a multiple myeloma patient with K light-chain cardiac amyloidosis.

作者信息

Dammassa Valentino, Greco Alessandra, Totaro Rossana, Colombo Costanza Natalia Julia, Raineri Claudia, Camporotondo Rita, De Ferrari Gaetano Maria, Mojoli Francesco, Arbustini Eloisa, Oltrona Visconti Luigi, Tavazzi Guido

机构信息

PhD in Experimental Medicine, University of Pavia, Pavia, Italy.

Adult Intensive Care Unit, Royal Brompton Hospital, Sydney Street, London, SW3 6NP, UK.

出版信息

Ann Hematol. 2022 Sep;101(9):2087-2088. doi: 10.1007/s00277-022-04858-z. Epub 2022 May 11.

DOI:10.1007/s00277-022-04858-z
PMID:35538262
Abstract
摘要

相似文献

1
Bortezomib-induced cardiogenic shock in a multiple myeloma patient with K light-chain cardiac amyloidosis.硼替佐米在一名患有K轻链型心脏淀粉样变性的多发性骨髓瘤患者中诱发心源性休克。
Ann Hematol. 2022 Sep;101(9):2087-2088. doi: 10.1007/s00277-022-04858-z. Epub 2022 May 11.
2
Cytomegalovirus reactivation after bortezomib treatment for multiple myeloma and light chain amyloidosis.硼替佐米治疗多发性骨髓瘤和轻链淀粉样变性后巨细胞病毒再激活。
Eur J Haematol. 2020 Mar;104(3):230-235. doi: 10.1111/ejh.13366. Epub 2020 Jan 10.
3
Herpesviral encephalitis associated with bortezomib use in a patient with multiple myeloma and associated light-chain amyloidosis.硼替佐米治疗多发性骨髓瘤及相关轻链淀粉样变性患者后引起的疱疹病毒性脑炎。
J Oncol Pharm Pract. 2022 Oct;28(7):1659-1663. doi: 10.1177/10781552221077956. Epub 2022 Feb 4.
4
Dexamethasone is associated with early deaths in light chain amyloidosis patients with severe cardiac involvement.地塞米松与伴有严重心脏受累的轻链淀粉样变性患者的早期死亡相关。
PLoS One. 2021 Sep 15;16(9):e0257189. doi: 10.1371/journal.pone.0257189. eCollection 2021.
5
Daratumumab, lenalidomide and dexamethasone in newly diagnosed systemic light chain amyloidosis patients associated with multiple myeloma.达雷妥尤单抗、来那度胺和地塞米松用于新诊断的与多发性骨髓瘤相关的系统性轻链淀粉样变患者
Br J Haematol. 2022 Aug;198(3):e38-e41. doi: 10.1111/bjh.18234. Epub 2022 May 7.
6
Efficacy of bortezomib, cyclophosphamide and dexamethasone in cardiac AL amyloidosis.硼替佐米、环磷酰胺和地塞米松治疗心脏淀粉样变性的疗效。
Intern Med J. 2022 Oct;52(10):1826-1830. doi: 10.1111/imj.15926.
7
Outcome of clinical experience of introducing a patient with secondary systemic AL-amyloidosis associated with multiple myeloma.引入伴有多发性骨髓瘤的继发系统性 AL 淀粉样变性症患者的临床经验结果。
Carcinogenesis. 2023 May 15;44(1):46-53. doi: 10.1093/carcin/bgad004.
8
[Outcomes of AL-amyloidosis treatment with bortezomib, dexamethasone and cyclophosphamide or doxorubicin-containing regimens].[硼替佐米、地塞米松和环磷酰胺或含阿霉素方案治疗AL淀粉样变性的结果]
Vnitr Lek. 2012 Dec;58(12):896-903.
9
Sustained improvement in cardiac function with persistent amyloid deposition in a patient with multiple myeloma-associated cardiac amyloidosis treated with bortezomib.硼替佐米治疗多发性骨髓瘤相关心脏淀粉样变性患者，心肌功能持续改善，淀粉样沉积物持续存在。
Int J Hematol. 2010 Nov;92(4):655-8. doi: 10.1007/s12185-010-0710-x. Epub 2010 Oct 27.
10
Proteasome inhibitors in AL amyloidosis: focus on mechanism of action and clinical activity.蛋白酶体抑制剂在AL淀粉样变性中的应用：聚焦作用机制与临床活性
Hematol Oncol. 2017 Dec;35(4):408-419. doi: 10.1002/hon.2351. Epub 2016 Sep 20.

引用本文的文献

1
Cardiac Toxicity in the Treatment of Light Chain Amyloidosis: Systematic Review of Clinical Studies.心脏毒性在轻链淀粉样变性治疗中的作用：临床研究的系统评价。
Curr Drug Saf. 2024;19(4):444-454. doi: 10.2174/0115748863264472231227060926.

本文引用的文献

1
Cardiovascular Complications of Proteasome Inhibitors Used in Multiple Myeloma.多发性骨髓瘤中使用蛋白酶体抑制剂的心血管并发症
Cardiol Rev. 2018 May/Jun;26(3):122-129. doi: 10.1097/CRD.0000000000000183.
2
Partially reversible bortezomib-induced cardiotoxicity: an unusual cause of acute cardiomyopathy.硼替佐米诱导的部分可逆性心脏毒性：急性心肌病的一种罕见病因。
J Community Hosp Intern Med Perspect. 2015 Dec 11;5(6):28982. doi: 10.3402/jchimp.v5.28982. eCollection 2015.
3
Severe heart failure after bortezomib treatment in a patient with multiple myeloma: a case report and review of the literature.
硼替佐米治疗多发性骨髓瘤患者后发生严重心力衰竭：病例报告及文献复习。
Acta Haematol. 2012;128(4):244-7. doi: 10.1159/000340050. Epub 2012 Sep 4.